Stereotaxis (STXS) Cash from Investing Activities (2010 - 2026)
Stereotaxis' (STXS) quarterly Cash from Investing Activities came in at -$79000.0 in Q1 2026, down 12.86% on a QoQ basis from -$70000.0 in Q4 2025.
Stereotaxis (STXS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 14 years of Cash from Investing Activities data on file, last reported at -$79000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$79000.0 in Q1 2026; TTM through Mar 2026 was -$151000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$93000.0, down 225.68% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$79000.0, down from -$70000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for STXS reached as high as $20.1 million in Q2 2023 and fell as low as -$20.1 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$216545.5 across 5 years, with a median of -$79000.0 in 2026.
- Across the five-year window, Cash from Investing Activities soared 3196.0% in 2023 and slumped 3400.0% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$20.1 million in 2022, then surged by 99.95% to -$10000.0 in 2023, then surged by 80.0% to -$2000.0 in 2024, then slumped by 3400.0% to -$70000.0 in 2025, then slipped by 12.86% to -$79000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$79000.0 in Q1 2026, -$70000.0 in Q4 2025, and -$2000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Stereotaxis | 128.56 Mn | 113.94 Mn | 3.79 Mn | -79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79,000.00 |
| Mar 31, 2026 | -79,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | 20.12 Mn |
| Jun 30, 2023 | 20.12 Mn |
| Mar 31, 2023 | -349,000.00 |
| Mar 31, 2023 | -349,000.00 |
| Dec 31, 2022 | -20.09 Mn |
| Dec 31, 2022 | -20.09 Mn |
| Sep 30, 2022 | -205,000.00 |
| Sep 30, 2022 | -205,000.00 |
| Jun 30, 2022 | -650,000.00 |
| Jun 30, 2022 | -650,000.00 |